“Proteomics International Laboratories has secured CE Mark registration for its PromarkerD as a diagnostic medical device.
PromarkerD is a world-first test for predicting the beginning of diabetic kidney disease. CE marking indicates a fitting in with health, safety and environmental protection standards for products sold within the European Economic Area.”
Article: Proteomics receives CE Mark for kidney disease test